Care Pathways

Goal: Monitor the progression of symptoms and the effectiveness of treatment, identify potential adverse reactions, reinforce recommendations to ensure understanding and adherence.

Ref.: World Health Organization (WHO)

Goal: Identify comorbidities and risk factors, encourage lifestyle changes, educate patients on the importance of adhering to the care plan.

Ref.: World Hypertension League (WHL) - CH

Goal: Identify at-risk patients, classify disease severity to guide appropriate management, and implement lifestyle changes.

Ref.: American Association for the Study of Liver Diseases (AASLD) - EUA

Goal: Identify early risks, adjust doses, minimize side effects, and standardize criteria for systemic therapy.

Ref.: STAR (Systemic Therapy Assessment Routine)

Goal: Identify COPD in its early stages, reduce the severity of exacerbations with prevention strategies, encourage physical exercises, and cessation of smoking.

Ref.: Global Initiative for Chronic Obstructive Lung Disease (GOLD) - EUA

Goal: Ensure proper glycemic control, monitor risk factors, and prevent chronic complications, offering continuous education to patients to encourage self-care.

Ref.: American Diabetes Association (ADA) - USA

Goal: Control disease progression and reduce debilitating symptoms, prevent and treat complications, and improve quality of life with multidisciplinary support and adequate symptom management.

Goal: Control disease progression, monitor and manage complications, promote adhesion to treatment and improve quality of life of the patient.

Goal: Control blood levels, prevent thromboembolic events, manage symptoms, and support patient psychosocial well-being.

Goal: Detect precocious complications, assess the efficacy of treatment with specific therapies, and promote quality of life for patients, providing continuous support for symptoms and emotional well-being.